Literature DB >> 26227392

Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF.

Tomoya Ueda1, Rika Kawakami, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Yukiji Takeda, Makoto Watanabe, Hiroyuki Kawata, Shiro Uemura, Yoshihiko Saito.   

Abstract

BACKGROUND: Heart failure (HF) with preserved (HFpEF) left ventricular ejection fraction (LVEF) is a syndrome with complex pathophysiology. Little is known about changes in LVEF that occur over time in HFpEF patients. A fundamental clinical question about HFpEF is whether HFpEF is an early manifestation of HF with reduced LVEF (HFrEF). If so, which patients with HFpEF are likely to show a decline in LVEF to less than 50%? The aim of the present study was to examine longitudinal changes in LVEF in patients with HFpEF. METHODS AND 
RESULTS: Among 279 consecutive HFpEF patients admitted as emergencies, we examined 100 who underwent echocardiography at least 1 year after discharge. EF >50% was used as the definition of HFpEF. During a mean duration from hospitalization to follow-up echocardiography of 31.5 months, 11% of patients had LVEF ≤50% (mildly reduced LVEF), known as mildly reduced (HFmrEF). The utility of LVEF during hospitalization to predict HFmrEF was assessed with receiver-operating characteristic curve analysis. A cutoff value of 55% had sensitivity of 90.9% and specificity of 97.7%. Logistic regression analysis indicated that LVEF ≤55% and ischemic etiology were strong predictors of progression from HFpEF to HFmrEF (odds ratio [OR] 435, 95% confidence interval [CI] 52.65-10,614, P<0.0001 and OR 10.9, 95% CI 2.60-74.80, P=0.0007, respectively).
CONCLUSIONS: The present study suggests that HFpEF patients with LVEF ≤55% may progress to HFmrEF in the future.

Entities:  

Mesh:

Year:  2015        PMID: 26227392     DOI: 10.1253/circj.CJ-15-0425

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  16 in total

1.  Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.

Authors:  Ryunosuke Okuyama; Junnichi Ishii; Hiroshi Takahashi; Hideki Kawai; Takashi Muramatsu; Masahide Harada; Akira Yamada; Sadako Motoyama; Shigeru Matsui; Hiroyuki Naruse; Masayoshi Sarai; Midori Hasegawa; Eiichi Watanabe; Atsushi Suzuki; Mutsuharu Hayashi; Hideo Izawa; Yukio Yuzawa; Yukio Ozaki
Journal:  Heart Vessels       Date:  2017-02-02       Impact factor: 2.037

2.  Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation.

Authors:  Hua He; XiaoDong Li; BingBing Ke; Zhuo Chen; FuSheng Han; YuJie Zeng
Journal:  J Interv Card Electrophysiol       Date:  2019-02-09       Impact factor: 1.900

3.  Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.

Authors:  Maxime Caru; Denis Corbin; Delphine Périé; Valérie Lemay; Jacques Delfrate; Simon Drouin; Laurence Bertout; Maja Krajinovic; Caroline Laverdière; Gregor Andelfinger; Daniel Sinnett; Daniel Curnier
Journal:  Clin Res Cardiol       Date:  2019-02-18       Impact factor: 5.460

4.  The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.

Authors:  Shuichi Kitada; Shohei Kikuchi; Takeshi Tsujino; Tohru Masuyama; Nobuyuki Ohte
Journal:  ESC Heart Fail       Date:  2017-09-21

Review 5.  Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression.

Authors:  George E Louridas; Katerina G Lourida
Journal:  J Cardiovasc Dev Dis       Date:  2016-09-08

Review 6.  Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.

Authors:  Alexander E Berezin
Journal:  J Circ Biomark       Date:  2016-03-16

7.  Characteristics and outcomes of transitions among heart failure categories: a prospective observational cohort study.

Authors:  Jun Gu; Zhao-Fang Yin; Hui-Li Zhang; Yu-Qi Fan; Jun-Feng Zhang; Chang-Qian Wang
Journal:  ESC Heart Fail       Date:  2020-01-27

8.  Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation.

Authors:  Kaeko Hirai; Rika Kawakami; Maki Nogi; Satomi Ishihara; Yukihiro Hashimoto; Yasuki Nakada; Hitoshi Nakagawa; Tomoya Ueda; Taku Nishida; Kenji Onoue; Tsunenari Soeda; Satoshi Okayama; Makoto Watanabe; Hiroyuki Okura; Yoshihiko Saito
Journal:  Circ Rep       Date:  2021-06-12

9.  Diagnostic accuracy of resting left ventricular akinesia/hypokinesia in predicting abnormal coronary angiography.

Authors:  Mohamed Faisal Lutfi
Journal:  BMC Cardiovasc Disord       Date:  2016-06-13       Impact factor: 2.298

10.  Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.

Authors:  Mariann Gyöngyösi; Noemi Pavo; Dominika Lukovic; Katrin Zlabinger; Andreas Spannbauer; Denise Traxler; Georg Goliasch; Ljubica Mandic; Jutta Bergler-Klein; Alfred Gugerell; Andras Jakab; Zsuzsanna Szankai; Levente Toth; Rita Garamvölgyi; Gerald Maurer; Frederic Jaisser; Faiez Zannad; Thomas Thum; Sándor Bátkai; Johannes Winkler
Journal:  J Transl Med       Date:  2017-10-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.